scylla and charybdis are both expressed during embryogenesis in dynamic, partially overlapping patterns. In contrast to the broadly expressed scylla mRNA, charybdis transcripts are predominantly restricted to neurons of the CNS and PNS as assessed by mRNA in situ hybridization. During late larval stages scylla mRNA is uniformly expressed without apparent tissue-specific distribution, whereas charybdis mRNA expression could not be detected in third instar imaginal discs (Reiling, 2004).
In order to identify novel genes involved in growth regulation by the Inr/TOR pathway, an EP overexpression screen was performed using a double-headed EP element. A genetically sensitized system involving coexpression of PKB and PDK1 (achieved by using EP837 that drives endogenous PDK1) was used in the eye; this leads to a big eye phenotype. Pilot experiments demonstrated that overexpression of PTEN or a dominant-negative version of the catalytic subunit of Drosopohila PI3K, Dp110, were not able to suppress the PKB/PDK1-dependent phenotype. Thus, the screening system is likely to identify components acting downstream of or in parallel to PKB/PDK1. For example, coexpression of Tsc1/Tsc2 strongly suppresses the phenotype of the tester flies (Reiling, 2004).
Two EP insertions (EP22.1, hereafter named EPscy, and EP9.85) were identified in the scylla locus as suppressors of the PKB/PDK1 bulging eye phenotype. BLASTP search with the Scylla amino acid sequence revealed another homologous protein encoded in the Drosopohila genome termed Charybdis. scylla (scy, CG7590) and charybdis (char, CG7533) are separated by ~232 kb of genomic DNA. Their gene products share a high degree of homology (38% identity, 49% similarity), suggestive of a gene duplication event. Whether charybdis overexpression would behave similarly to scylla was examined in the PKB/PDK1 overexpression assay using EP1035 (hereafter named EPchar). Indeed, the big eye phenotype of the tester system is also suppressed by EPchar. UAS transgenes with either the scylla or charybdis cDNA recapitulate the suppression phenotype of the corresponding EP element. Coexpression of scylla and charybdis further ameliorates the suppression phenotype to a nearly wild-type situation. Notably, scylla or charybdis overexpression on their own using a panel of different eye/wing Gal4 drivers reduces adult organ size. Coexpression of the caspase inhibitors p35 or DIAP1 does not rescue the small eye phenotype induced by expression of either scylla or charybdis in the eye. Moreover, no elevated cell death in eye imaginal discs overexpressing scylla/ charybdis under control of the GMR-Gal4 driver was observed by acridine orange staining. This suggests that apoptosis is not the cause for the eye size reduction. Thus, scylla and charybdis overexpression antagonizes the growth-promoting effects of PKB/PDK1 and is sufficient to negatively regulate growth (Reiling, 2004).
To investigate the function of Scylla and Charybdis in more detail, loss-of-function mutations were generated in both genes and the analysis was complemented with overexpression studies. Partial scylla deletions were obtained by imprecise excisions of EP9.85, which is integrated in the scylla open reading frame (ORF) and therefore already represents a scylla allele (hereafter named scyEP9.85). For charybdis, a local hop strategy of EPchar was used to obtain char180, constituting a new EP insertion (EP1035*) in the charybdis 5'-untranslated region (UTR) plus the original EPchar. Quantitative real time-PCR showed that in char180 homozygotes, charybdis mRNA expression is decreased to ~25% of wild-type levels. It is assumed that this charybdis allele is a strong hypomorph, since mRNA levels were only slightly more reduced (to 23% or 15%, respectively) when RNA was extracted from flies heterozygous for char180 over either one of two independent deficiencies uncovering charybdis and scylla (Reiling, 2004).
All scylla mutant combinations and the char180 homozygotes are viable and fertile without apparent mutant phenotype. scylla and char180 mutant animals have the same weight as control flies. Measurement of wing size and hair density in the adult wing of scylla mutants revealed no differences in cell size and cell number as compared to control animals. scylla loss-of-function clones were created in imaginal disks using FLP/FRT-mediated mitotic recombination to test the effect on growth properties of the mutant tissue. One would expect a growth advantage of cells in clones lacking a bona fide negative growth regulator, as is the case for PTEN. However, larval scylla mutant clones were the same size as their wild-type sister clones. Likewise, clones obtained in adult eyes revealed no increase in cell size of scylla or char180 mutant ommatidia. Thus, loss of Scylla or Charybdis function is dispensable for growth under normal conditions. It is conceivable that Scylla and Charybdis act in a redundant manner. Therefore, it was important to create scylla charybdis double mutants (Reiling, 2004).
char180 were combined with three of scylla alleles by meiotic recombination. All double-mutant scylla charybdis combinations produced viable adult flies. Weight analysis of heteroallelic scylla charybdis flies demonstrated that simultaneous loss of Scylla and Charybdis significantly increases body weight. Consistent results were obtained by combining one copy of scyEP9.85/31/113 char180 and the deficiency Df(3L)vin4 uncovering scylla and charybdis. Mutant females were on average 6%-23% and males 9%-17% heavier than control flies. Conversely, ubiquitous scylla/charybdis overexpression using the Act5CGal4 driver generated flies that are decreased in size and weight (15.1% using EPscy and 14.3% using UAS-char#53). The majority of scylla/charybdis-overexpressing flies eclosed with a minor delay (0.5-1 d) (Reiling, 2004).
To assess whether charybdis/scylla overexpression affects cell size, scylla and charybdis gain-of-function flip-out clones in the eye, marked by the absence of the red pigment, were generated. A moderate reduction in cell size was observed in cells overexpressing scylla or charybdis. Ommatidia overexpressing scylla or charybdis exhibit no patterning defects. In contrast, simultaneous removal of Scylla and Charybdis in clones of photoreceptor cells resulted in slightly enlarged cells. Consistently, when most of the head capsule and the eyes were made homozygous by means of the eyflp/FRT system in an otherwise heterozygous mutant background, a mild big head phenotype was generated in the double mutant but not in either single mutant (Reiling, 2004).
The gain-of-function clonal analysis in the eye showed that cell size is reduced upon forced scylla/charybdis expression, but it did not address the question whether cell number is affected. To clarify this issue, the wing size and cell number of flies that ubiquitously overexpress scylla were measured. The insect wing is a double-layered epithelial structure, and each cell in the wing secretes a single hair (trichome). Therefore, by counting the number of trichomes per defined area, hair density can be taken as a measure for cell number. Overall wing size was reduced by ~25% in males or ~15% in females overexpressing scylla. By extrapolating the number of cells per measured area, it was found that cell size is decreased by ~29% in males and ~21% in females. It is concluded that the size reduction brought about by overexpressing scylla is caused by a reduction in cell size. Cell density is even slightly increased (5.8% in males, 7.6% in females). The data show that Scylla and Charybdis have a growth-inhibitory role and that they share some functional redundancy (Reiling, 2004).
Reference names in red indicate recommended papers.
Brugarolas, J., et al. (2004). Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev. 2004 18(23): 2893-904. 15545625
Chauvet, S., Maurel-Zaffran, C., Miassod, R., Jullien, N., Pradel, J., Aragnol, D. (2000). Characterization of charybde and scylla, two paralogous target genes of Hox and cofactor proteins in Drosophila. GenBank, Direct Submission
Corradetti, M. N., Inoki, K. and Guan, K. L. (2005). The stress-inducted proteins RTP801 and RTP801L are negative regulators of the mammalian target of rapamycin pathway. J. Biol. Chem. 280(11): 9769-72. 15632201
DeYoung, M. P., et al. (2008). Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev. 22: 239-251. PubMed Citation: 18198340
Ellisen, L. W., et al. (2002). REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol. Cell 10: 995-1005. 12453409
Frei, C. and Edgar, B.A. (2004). Drosophila cyclin D/Cdk4 requires Hif-1 prolyl hydroxylase to drive cell growth. Dev. Cell 6: 241-251. 14960278
Harvey, K. F., et al. (2008). FOXO-regulated transcription restricts overgrowth of Tsc mutant organs. J. Cell Biol. 180(4): 691-6. PubMed Citation: 18299344
Kimura, N., Tokunaga, C., Dalal, S., Richardson, C., Yoshino, K., Hara, K., Kemp, B. E., Witters, L. A., Mimura, O. and Yonezawa, K. (2003). A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway. Genes Cells 8: 65-79. 12558800
Ma, L., et al. (2005). Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression. Genes Dev. 19: 1779-1786. PubMed Citation: 16027168
Manning, B. D., et al. (2005). Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2. Genes Dev. 19: 1773-1778. PubMed Citation: 16027169
Reiling, J. H. and Hafen, E. (2004). The hypoxia-induced paralogs Scylla and Charybdis inhibit growth by down-regulating S6K activity upstream of TSC in Drosophila. Genes Dev. 18(23): 2879-92. 15545626
Schwarzer R, Tondera, D., Arnold, W., Giese, K., Klippel, A. and Kaufmann, J. (2005). REDD1 integrates hypoxia-mediated survival signaling downstream of phosphatidylinositol 3-kinase. Oncogene 24(7): 1138-49. 15592522
Scuderi, A., Simin, K., Kazuko, S. G., Metherall, J. E. and Letsou, A. (2006). scylla and charybde, homologues of the human apoptotic gene RTP801, are required for head involution in Drosophila. Dev. Biol. 291(1): 110-22. 1642334
Shoshani, T., Faerman, A., Mett, I., Zelin, E., Tenne, T., Gorodin, S., Moshel, Y., Elbaz, S., Budanov, A., Chajut, A., et al. (2002). Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol. Cell. Biol. 22: 2283-2293. 11884613
Sofer, A., Lei, K., Johannessen, C. M. and Ellisen, L. W. (2005). Regulation of mTOR and cell growth in response to energy stress by REDD1. Mol. Cell. Biol. 25(14): 5834-45. 15988001
Wang, Z., Malone, M. H., Thomenius, M. J., Zhong, F., Xu, F. and Distelhorst, C. W. (2003). Dexamethasone-induced gene 2 (dig2) is a novel pro-survival stress gene induced rapidly by diverse apoptotic signals. J. Biol. Chem. 278: 27053-27058. 12736248
Zinke, I., Schutz, C. S., Katzenberger, J. D., Bauer, M. and Pankratz, M. J. (2002). Nutrient control of gene expression in Drosophila: Microarray analysis of starvation and sugar-dependent response. EMBO J. 21: 6162-6173. 12426388
date revised: 25 February 2009
Home page: The Interactive Fly © 2003 Thomas B. Brody, Ph.D.
The Interactive Fly resides on the
Society for Developmental Biology's Web server.